STOCK-BASED COMPENSATION (Tables)

6 Months Ended

Jul. 29, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of company's stock-based compensation

A summary of the Company’s stock-based compensation (a component of selling, general and administrative expenses) and related income tax benefit is as follows:

(in thousands):

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
	July 29, 2017		July 30, 2016		July 29, 2017		July 30, 2016
Stock option expense	$	442	$	304	$	969	$	(120	)
Restricted stock expense		1,448		387		2,014		1,513
ESPP expense		93		51		185		103
Total stock-based compensation	$	1,983	$	742	$	3,168	$	1,496
Income tax benefit on stock-based compensation	$	538	$	170	$	791	$	379

Schedule of stock option granted using the Black-Scholes option-pricing model

The fair value of each option granted during the thirteen and twenty-six week periods ended July 29, 2017 and July 30, 2016 is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:

	Thirteen Weeks Ended						Twenty-Six Weeks Ended
	July 29, 2017			July 30, 2016			July 29, 2017			July 30, 2016
Stock Options
Expected volatility		43.9	%		33.2	%		41.5	%		33.3	%
Risk-free interest rate		2.0	%		1.4	%		2.1	%		1.5	%
Expected option life (in years)		5.84			5.84			5.84			5.84
Expected dividend yield		1.87	%		1.80	%		1.86	%		1.79	%
Weighted average fair value at grant date	$	4.99		$	4.05		$	4.35		$	4.06
Employee Stock Purchase Plan
Expected volatility		98.8	%		60.3	%		80.3	%		59.8	%
Risk-free interest rate		1.0	%		0.9	%		1.0	%		0.9	%
Expected option life (in years)		0.50			0.50			0.38			0.38
Expected dividend yield		0.78	%		0.79	%		0.59	%		0.59	%
Weighted average fair value at grant date	$	7.67		$	3.78		$	6.31		$	3.60

Schedule of stock option activity

The following table summarizes stock option activity during the twenty-six weeks ended July 29, 2017:

	Options			Weighted- Average Exercise Price		Weighted-Average Contractual Life (years)		Aggregate Intrinsic Value (000s)
Outstanding at January 28, 2017		1,607,656		$	13.55		6.0	$	2,070
Granted		215,573			12.40
Cancelled		(120,140	)		15.19
Exercised		—			—
Outstanding at July 29, 2017		1,703,089		$	13.29		5.7		—
Exercisable at July 29, 2017		319,403		$	15.66		4.7		—

Schedule of restricted stock activity

The following table summarizes restricted stock activity during the twenty-six weeks ended July 29, 2017:

	Number of Shares			Weighted-Average Grant Date Fair Value
Non-vested Restricted Stock at January 29, 2017		598,784		$	15.08
Granted		182,124			12.18
Forfeited / Cancelled		(36,647	)		18.18
Vested		(219,886	)		15.09
Non-vested Restricted Stock at July 29, 2017		524,375		$	13.86